Bank of Hawaii Director Liquidates Trust Position Following CEO Transition Announcement

The Motley FoolThe Motley Fool
|||1 min read
Key Takeaway

Bank of Hawaii director Robert Wo Jr. sold 5,000 shares worth $393,000 following the CEO's announced retirement in March 2026, amid the bank's stock decline.

Bank of Hawaii Director Liquidates Trust Position Following CEO Transition Announcement

Robert W. Wo Jr., a director at Bank of Hawaii, sold 5,000 shares valued at approximately $393,000 from his trust following the bank's announcement that its chief executive officer will retire at the end of March 2026. The transaction represents a partial reduction in Wo's holdings at the institution, though he retains substantial shares across multiple entities.

The director's share sale comes amid ongoing challenges for the regional lender, which has experienced four consecutive years of stock price decline and faces operational headwinds stemming from its geographic concentration in the Pacific Islands market. The CEO transition represents a significant inflection point for the organization as it navigates both leadership changes and broader market pressures.

Wo's continued equity stake across multiple accounts indicates maintained confidence in the institution despite the recent market performance and upcoming executive transition. The bank has not yet announced a timeline or process for identifying a successor to the retiring chief executive.

Source: The Motley Fool

Back to newsPublished Feb 22

Related Coverage

The Motley Fool

Trupanion CFO Completes Systematic Stock Divestment With Final Share Sale

Trupanion CFO completed nine-month systematic stock divestment of 19,859 shares via pre-planned 10b5-1 trading arrangement, signaling financial diversification rather than company concerns.

TRUP
GlobeNewswire Inc.

Corcept Therapeutics Faces Class Action Over FDA Rejection; Stock Crashed 50%

Corcept Therapeutics faces securities fraud lawsuit after FDA rejected relacorilant application. Stock plummeted 50.4% following December rejection. Investor deadline April 21, 2026.

CORT
Investing.com

D-Wave's 44% Plunge Masks Quantum Leap: Growth Story vs. Valuation Reality

D-Wave ($QBTS) fell 44% in 2026 despite strong bookings exceeding 2025 totals and $30M in major deals. Analysts see 132% upside, but 237x sales valuation remains extreme.

QBTS
GlobeNewswire Inc.

OneMain Holdings Faces Multi-State Securities Probe Over Alleged Lending Fraud

Pomerantz Law Firm investigates $OMF following multi-state lawsuit alleging deceptive lending practices. Stock tumbles 5.38% on fraud allegations.

OMF
The Motley Fool

C3.ai Executive Chairman Dumps $4.4M in Shares Amid Stock Decline and Leadership Turmoil

C3.ai executive chairman sold $4.4M in shares via pre-planned trading arrangement amid 46% revenue decline and CEO transition.

AI
GlobeNewswire Inc.

Boston Scientific Faces Securities Fraud Lawsuit Over Overstated EP Growth Claims

Boston Scientific faces class action lawsuit alleging material misstatements about electrophysiology growth. Stock fell 17.6% after disclosing slower market growth and competitive pressures.

BSX